CoChat

Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis

Bayona, Ane, Martínez-Vaello, Victoria, Zamora, Javier, Nattero-Chávez, Lía, Luque-Ramírez, Manuel, Escobar-Morreale, Héctor F · 2022 · Human Reproduction Update

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.

Abstract

BACKGROUND: An increased prevalence of functional hyperandrogenism—including polycystic ovary syndrome (PCOS)—has been described in women with type 1 diabetes (T1D). However, heterogeneity between studies is frequent, and prevalence rates vary according to different criteria used for the diagnosis of PCOS and the population studied. OBJECTIVE AND RATIONALE: We aimed to perform a systematic review and meta-analysis of the prevalence of PCOS and related hyperandrogenic traits in premenopausal women with T1D. This way, we intend to increase the precision of the estimates of prevalence of PCOS and related traits in women with T1D, and to explore sources of heterogeneity while providing prevalence estimates for clinically relevant subgroups such as the different phenotypes. SEARCH METHODS: We conducted a systematic review of the literature using Medline-OVID and Embase databases (Open Science Framework registry for systematic review protocols, https://osf.io/6cv9p/). Studies published up to 29 March 2021 were considered. We selected cross-sectional or prospective studies that reported, in patients with T1D, prevalence data on PCOS according to current definitions and different phenotypes, and/or prevalence rates of other related traits (hirsutism, hyperandrogenaemia, oligo-amenorrhoea and/or polycystic ovarian morphology: PCOM). Exclusion criteria for the review were studies addressing types of diabetes other than T1D; and studies using diagnostic definitions of PCOS different than those mentioned above. Two independent researchers performed data extraction. To assess the risk of bias, we used a tool developed specifically to appraise population-based prevalence studies. OUTCOMES: We selected 19 studies (1042 women) reporting the prevalence of PCOS and/or other hyperandrogenic traits. Regarding bias, 12 studies were considered of low-risk, and the remaining seven studies were considered intermediate risk. The pooled prevalence of PCOS when considering all possible phenotypes (ESHRE- American Society for Reproductive Medicine criteria) in T1D was 26% (95% CI: 19–34%; 13 studies, 684 women). Pooled prevalence of classic PCOS (US National Institutes of Health criteria) was 16% (95% CI: 10–22%; 9 studies, 614 women). Pooled prevalence of hyperandrogenic PCOS (Androgen Excess and PCOS Society criteria) was 26% (95% CI: 16–41%; 5 studies, 329 women). Hirsutism (24%), hyperandrogenaemia (29%), oligomenorrhoea (24%) and PCOM (34%) were also prevalent. Heterogeneity was high in almost all these meta-analyses. WIDER IMPLICATIONS: This systematic review and meta-analysis showed that PCOS and related hyperandrogenic traits are present in approximately one in every four women with T1D. Larger studies are needed to confirm this association, to address the effect of different variables on the occurrence of PCOS.

Overview

Integrity signals

Registry

Crossref · 10.1093/humupd/dmac011

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 6

  1. Calliari, 2014, Polycystic ovary syndrome and hyperandrogenism in type 1 diabetes: Adolescent girls are already at risk, Pediatr Diabetes, 15, 106
  2. Dabadghao, 2016, Prevalence of polycystic ovary syndrome and its clinical profile in young females with type 1 diabetes mellitus, Horm Res Paediatr, 86, 238
  3. Deja, 2010, Clinical and hormonal profile in adolescent girls with type 1 diabetes mellitus and polycystic vary syndrome or polycystic ovary morphology, Pediatr Diabetes, 11, 20
  4. Deja, 2009, PCOS and hyperandrogenic disorders—a problem in adolescent girls with type 1 diabetes mellitus and good metabolic control, Pediatr Diabetes, 10, 99
  5. Kvasnickova, 2010, Occurrence of polycystic ovary syndrome and hyperadrogenemia in women with type 1 diabetes mellitus, Prakt Lek, 90, 224
  6. Zawadzki, 1992, Polycystic Ovary Syndrome, 377

Cited by

See all 54

Metadata

Authors
Bayona, A., Martínez-Vaello, V., Zamora, J., Nattero-Chávez, L., Luque-Ramírez, M., & Escobar-Morreale, H. F.
Affiliations
  • Universidad de Alcalá (ES)
  • Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal , Madrid, Spain
  • Instituto Ramón y Cajal de Investigación Sanitaria (ES)
Venue
Human Reproduction Update
Published
2022-03-03
Volume
28
Issue
4
Pages
501-517
ISSN
  • 1355-4786 (ISSN-L)
  • 1460-2369
OpenAlex
W4212965655
Cited by
44
References
46
Citations by year
2026: 8 · 2025: 14 · 2024: 10 · 2023: 9 · 2022: 3
FWCI
1.49
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction Update (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • Instituto de Salud Carlos III (PIE16/00050)
  • European Development Regional Fund ‘A way (CM19/00138)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
polycystic ovary syndrome, type 1 diabetes, hyperandrogenism, PCOS phenotypes, hirsutism, hyperandrogenemia, polycystic ovary morphology, prevalence, premenopausal women, NIH criteria
MeSH terms
Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Hirsutism, Humans, Phenotype, Polycystic Ovary Syndrome, Prospective Studies, Prevalence, Hyperandrogenism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.